Accelerate Diagnostics Inc. - notizie pubblicate 236 - letture 5.800


Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Current Report - Form 8-K

United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...

13.04.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Current Report - Form 8-K

United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...

06.04.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

05.04.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Initial Statement of Beneficial Ownership - Form 3

Form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section 16(a) of the securit ...

05.04.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Annual Report for Fiscal Year Ending December 31, 2022 (Form 10-K)

The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer accelerate diagnosti ...

31.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Securities Purchase Agreement - Form 8-K

United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...

30.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

Tucson, ariz., march 29, 2023/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) today announced financial results for the fourth quarter and year ended december 31, 2022. ...

29.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results - Form 8-K

The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer accelerate diagnosti ...

29.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

15.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

15.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results

Tucson, ariz., march 15, 2023/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) announced today that management will host a conference call on wednesday, march 29, 2023, a ...

15.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement

Tucson, ariz., march 14, 2023/prnewswire/ -- accelerate diagnostics, inc. (nasdaq:axdx) a leading provider of innovative rapid diagnostic solutions, announced today that steve reic ...

15.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Management Change - Form 8-K

United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...

14.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Material Agreement - Form 8-K

United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...

14.03.2023
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

13.03.2023
Condividi